Literature DB >> 31033946

Intracranial Pharmacotherapy and Pain Assays in Rodents.

Erik Martinez1, Haocheng Zhou1, Jing Wang2.   

Abstract

Pain is a salient sensory experience with affective and cognitive dimensions. However, central mechanisms for pain remain poorly understood, hindering the development of effective therapeutics. Intracranial pharmacology presents an important tool for understanding the molecular and cellular mechanisms of pain in the brain, as well as for novel treatments. Here we present a protocol that integrates intracranial pharmacology with pain behavior testing. Specifically, we show how to infuse analgesic drugs into a select brain region, which may be responsible for pain modulation. Furthermore, to determine the effect of the candidate drug in the central nerve system, pain assays are performed after intracranial treatment. Our results demonstrate that intracranial administration of analgesic drugs in a targeted region can provide relief of pain in rodents. Thus, our protocol successfully demonstrates that intracranial pharmacology, combined with pain behavior testing, can be a powerful tool for the study of pain mechanisms in the brain.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31033946      PMCID: PMC6784831          DOI: 10.3791/58473

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  10 in total

1.  Anaesthetisation of prefrontal cortex and response to noxious stimulation.

Authors:  S J Cooper
Journal:  Nature       Date:  1975-04-03       Impact factor: 49.962

2.  AMPAkines and morphine provide complementary analgesia.

Authors:  Yongjun Sun; Kevin Liu; Erik Martinez; Jahrane Dale; Dong Huang; Jing Wang
Journal:  Behav Brain Res       Date:  2017-07-19       Impact factor: 3.332

3.  AMPAkines have novel analgesic properties in rat models of persistent neuropathic and inflammatory pain.

Authors:  Alexander M Le; Michelle Lee; Chen Su; Anthony Zou; Jing Wang
Journal:  Anesthesiology       Date:  2014-11       Impact factor: 7.892

4.  Activation of corticostriatal circuitry relieves chronic neuropathic pain.

Authors:  Michelle Lee; Toby R Manders; Sarah E Eberle; Chen Su; James D'amour; Runtao Yang; Hau Yueh Lin; Karl Deisseroth; Robert C Froemke; Jing Wang
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

5.  DMSO as a vehicle for central injections: tests with feeding elicited by norepinephrine injected into the paraventricular nucleus.

Authors:  J Ernie Blevins; B Glenn Stanley; Roger D Reidelberger
Journal:  Pharmacol Biochem Behav       Date:  2002 Jan-Feb       Impact factor: 3.533

6.  Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state.

Authors:  Yossef Goffer; Duo Xu; Sarah E Eberle; James D'amour; Michelle Lee; David Tukey; Robert C Froemke; Edward B Ziff; Jing Wang
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

7.  Hypocretin Neurotransmission Within the Central Amygdala Mediates Escalated Cocaine Self-administration and Stress-Induced Reinstatement in Rats.

Authors:  Brooke E Schmeichel; Melissa A Herman; Marisa Roberto; George F Koob
Journal:  Biol Psychiatry       Date:  2016-06-16       Impact factor: 13.382

8.  AMPAkines Target the Nucleus Accumbens to Relieve Postoperative Pain.

Authors:  Chen Su; Hau Yeuh Lin; Runtao Yang; Duo Xu; Michelle Lee; Natalie Pawlak; Monica Norcini; Alexandra Sideris; Esperanza Recio-Pinto; Dong Huang; Jing Wang
Journal:  Anesthesiology       Date:  2016-11       Impact factor: 7.892

9.  AMPA receptor subunit GluR1 downstream of D-1 dopamine receptor stimulation in nucleus accumbens shell mediates increased drug reward magnitude in food-restricted rats.

Authors:  K D Carr; L S Chau; S Cabeza de Vaca; K Gustafson; M Stouffer; D S Tukey; S Restituito; E B Ziff
Journal:  Neuroscience       Date:  2009-11-24       Impact factor: 3.590

10.  Corticostriatal Regulation of Acute Pain.

Authors:  Erik Martinez; Harvey H Lin; Haocheng Zhou; Jahrane Dale; Kevin Liu; Jing Wang
Journal:  Front Cell Neurosci       Date:  2017-05-26       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.